Cosmetic cross-reference

Calcium Lactate

CAS 814-80-2

Calcium Lactate (CAS 814-80-2) is a Phase 1 pharmaceutical compound with 0 bioactivity targets and 1,786 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
1,786
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Calcium Lactate
CAS Number
814-80-2
UNII
2URQ2N32W3
InChIKey
MKJXYGKVIBWPFZ-UHFFFAOYSA-L
ChEMBL ID
CHEMBL2106111
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
CALCIUM LACTATE ANHYDROUS
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 1
Early-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL2106111 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 5 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Osteonecrosis of jaw 44 115.636 10064658
Hypocalcaemia 40 98.298 10020947
Atypical femur fracture 11 37.391 10070884
Hypercalcaemia 18 34.261 10020583
Platelet count decreased 30 26.669 10035528

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
CALCIUM LACTATE 47622 SU MTHSPL
CALCIUM LACTATE ANHYDROUS 2697131 SU MTHSPL
calcium lactate 47622 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Calcium Lactate used for in pharmaceutical contexts?

Calcium Lactate (CAS 814-80-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Calcium Lactate?

Calcium Lactate has 1,786 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Osteonecrosis of jaw, Hypocalcaemia, Atypical femur fracture, Hypercalcaemia, Platelet count decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Calcium Lactate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Lactate with EU status "permitted".

What clinical phase is Calcium Lactate in?

Calcium Lactate is rendered with ChEMBL max phase 1.